Adenosine instead of supranormal potassium in cardioplegic solution preserves endothelium-derived hyperpolarization factor-dependent vasodilation

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 1, 2008, Pages 18-24

  Jakobsen, Øyvind ^a   Stenberg, Thor A ^a   Losvik, Ole ^a   Ekse, Sveinung ^a   Sørlie, Dag G ^a   Ytrebø, Lars M ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Adenosine; Cardioplegia; Cardiopulmonary bypass; Coronary flow; Endothelium; Vascular relaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETIC ACID; ADENOSINE; APAMIN; BRADYKININ; CALCIUM CHLORIDE; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEPARIN; INDOMETACIN; MAGNESIUM CHLORIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHLORIDE; PROCAINE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM CHLORIDE; ST THOMAS HOSPITAL SOLUTION; THROMBOXANE A2 DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CRYSTALLOID; HEART MUSCLE BLOOD FLOW; HEART PROTECTION; HYPERKALEMIA; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADENOSINE; ANIMALS; BIOLOGICAL FACTORS; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CORONARY CIRCULATION; FEMALE; HEART ARREST, INDUCED; HEMODYNAMICS; MALE; MYOCARDIAL REPERFUSION INJURY; POTASSIUM; RANDOM ALLOCATION; TREATMENT OUTCOME; VASODILATION; VASODILATOR AGENTS;

EID: 37249028573     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.10.013     Document Type: Article

References (25)

1. Sellke F.W., Friedman M., Dai H.B., Shafique T., Schoen F.J., Weintraub R.M., and Johnson R.G. Mechanisms causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion. Cardiovasc Res 27 (1993) 1925-1932
2. Mankad P.S., Chester A.H., and Yacoub M.H. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg 51 (1991) 89-93
3. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol Sci 23 (2002) 374-380
4. Ge Z.D., and He G.W. Altered endothelium-derived hyperpolarizing factor-mediated endothelial function in coronary microarteries by St. Thomas' Hospital solution. J Thorac Cardiovasc Surg 118 (1999) 173-180
5. He G.W., and Yang C.Q. Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncyclooxygenase pathway: a mechanism for coronary dysfunction due to cardioplegia. Ann Thorac Surg 61 (1996) 1394-1399
6. Lindal S., Vaage J., Olsen R., Straume B.K., Jorgensen L., and Sorlie D. Endothelial injury and trapping of blood cells in human myocardium following coronary bypass surgery. Scand Cardiovasc J 33 (1999) 143-150
7. Vinten-Johansen J., Thourani V.H., Ronson R.S., Jordan J.E., Zhao Z.Q., Nakamura M., Velez D., and Guyton R.A. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68 (1999) 1942-1948
8. Jakobsen O., Muller S., Aarsaether E., Steensrud T., and Sorlie D.G. Adenosine instead of supranormal potassium in cardioplegic solution improves cardioprotection. Eur J Cardiothorac Surg 32 (2007) 493-500
9. Berne R.M. The role of adenosine in the regulation of coronary blood flow. Circ Res 47 (1980) 807-813
10. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50 (1998) 413-492
11. Mills I., and Gewirtz H. Cultured vascular smooth muscle cells from porcine coronary artery possess A1 and A2 adenosine receptor activity. Biochem Biophys Res Commun 168 (1990) 1297-1302
12. Olanrewaju H.A., Qin W., Feoktistov I., Scemama J.L., and Mustafa S.J. Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 279 (2000) H650-H656
13. Hein T.W., Belardinelli L., and Kuo L. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther 291 (1999) 655-664
14. Budde J.M., Morris C.D., Velez D.A., Muraki S., Wang N.P., Guyton R.A., and Zhao Z.Q. Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended reperfusion. J Surg Res 116 (2004) 104-115
15. Babbitt D.G., Virmani R., and Forman M.B. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 80 (1989) 1388-1399
16. Jordan J.E., Zhao Z.Q., Sato H., Taft S., and Vinten-Johansen J. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280 (1997) 301-309
17. Corvera J.S., Kin H., Dobson G.P., Kerendi F., Halkos M.E., Katzmark S., Payne C.S., Zhao Z.Q., Guyton R.A., and Vinten-Johansen J. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg 129 (2005) 599-606
18. Moser G.H., Schrader J., and Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256 (1989) C799-C806
19. He G.W. Endothelial function related to vascular tone in cardiac surgery. Heart Lung Circ 14 (2005) 13-18
20. Ekse S., Clapp L.H., Revhaug A., and Ytrebo L.M. Endothelium-derived hyperpolarization factor (EDHF) is up-regulated in a pig model of acute liver failure. Scand J Gastroenterol 42 (2007) 356-365
21. Tsao P.S., Ma X.L., and Lefer A.M. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J 123 (1992) 1464-1471
22. Zhao Z.Q., Sato H., Williams M.W., Fernandez A.Z., and Vinten-Johansen J. Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol 271 (1996) H1456-H1464
23. Nolte D., Lorenzen A., Lehr H.A., Zimmer F.J., Klotz K.N., and Messmer K. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol 346 (1992) 234-237
24. Peart J.N., and Headrick J.P. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114 (2007) 208-221
25. Steensrud T., Nordhaug D., Husnes K.V., Aghajani E., and Sorlie D.G. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts. Ann Thorac Surg 77 (2004) 1391-1397